This study aims to addresses two important gaps in knowledge by comparing novel inflammatory markers (HBP and SAA) against established markers (IL-6 and CRP) to characterize inflammatory phenotypes associated with tissue damage and viral load in COVID-19 [21, 23, 44]. This evidence concerns the gene CRP and COVID-19.